STIIX Virtual Conference Series 2025
STI rates in the US continue to cause significant concern. Amid growing need and tightening budgets, improving access to sexual health services remains a major challenge.
Building on our summer series, this new series focused on one innovative approach that is having a significant impact on public health in other parts of the world: at-home STI testing focusing on HIV, STIs and viral hepatitis.
This four-part series looked at home testing / home self-collection in detail, and how we can enhance and tackle STI rates with constrained public health budgets. If you missed the sessions, you can view three of the videos by submitting your contact details here.
​
Below are the sessions we held throughout the series:
-
14th January - How home testing is improving a state sexual health program
-
28th January - Public policy towards STI home testing with a changing government
​
We were delighted to have the following speakers across this series:
​
​
Dr. Leandro A. Mena, MD, MPH, a physician and public health expert specializing in infectious diseases and sexual health. Former Director of the CDC’s Division of STD Prevention, he has held leadership roles advancing healthcare for underserved communities and authored numerous influential publications.
Dr. Barbara Van Der Pol, PhD, MPH, an infectious diseases expert and Director of the UAB Heersink School of Medicine's STD Clinical Research Organization. Her work focuses on healthcare behaviours, point-of-care diagnostics, and STI testing innovations. She leads a CDC-funded project on vaccine acceptability and STI services in underserved communities and collaborates with the WHO to set global STI research and diagnostic standards. A global leader in sexual health, she chairs the FDA's Microbiology Devices Panel and is President of the International Society for STD Research.
Dr. Stephen J. Jordan, MD, PhD, is an Assistant Professor of Medicine at Indiana University and a physician-scientist specializing in sexually transmitted infections (STIs), particularly chlamydia. He treats patients at the Marion County Bell Flower Clinic and leads a translational research program on chlamydia. Dr. Jordan serves on the editorial board of Sexually Transmitted Diseases and has advised the CDC on pelvic inflammatory disease. He is also the Laboratory Director for Preventx.
David Harvey is the Executive Director of the National Coalition of STD Directors (NCSD) and a seasoned leader in public health and advocacy. He has held executive roles at AIDS Alliance for Children, Youth & Families and Preliteracy and has served on national boards and panels, including the U.S. National Commission for UNESCO.
Bettillou Taylor is a distinguished expert in federal appropriations with over 35 years of senior experience on the House and Senate Appropriations Committees. She has led bipartisan efforts to advance legislative priorities across sectors including public health, education and defence.
Nick Malhomme is the US Country Director of Preventx. Nick has worked on public health projects for nearly 20 years and leads the US arm of Preventx, leaders in the field of home self-collection, via a lab located in Ohio and a dedicated technology platform. Beyond their work in 17 states in the US, Preventx runs the worlds two largest public health programs – Sexual Health London and the UK National Hepatitis Testing Service – testing over 1m people with an 82% return rate.
We hope you can join these insightful webinar sessions with leading experts addressing some of the most pressing challenges in sexual health.
STIIX Virtual Conference Series 2024
The STIIX Virtual Conference Series 2024 brought together our network of leading consultants, clinicians and academics to address the pressing issues in sexual health and HIV.
Our theme was: Addressing inequalities in sexual health and HIV. STI rates in the US continue to cause significant concern, and improving access to sexual health services for everyone is vital. But despite progress being made, barriers to uptake including socioeconomic disparities, stigma and discrimination put our efforts at risk.​​
About us
The STI International Exchange (STIIX) is a not-for-profit group designed to advance thinking in sexual health testing and treatment through international collaboration and problem-solving.
STIIX takes a close-knit, problem-solving approach to solving real world problems related to sexual health. While there are international forums to present research and findings to a large group, this practical approach sets STIIX apart.
The group meets monthly on a virtual basis, and we held our first ‘in-person’ conference in London on 26 & 27 October 2022.
Our members come from senior-level government, public health, laboratory (public and private) and non-profits, and have a direct influence over STI testing and treatment with the common goal of making these accessible to a wider-number of people, across the globe.
